These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2081089)

  • 21. Antiangiogenic therapy: a universal chemosensitization strategy for cancer?
    Kerbel RS
    Science; 2006 May; 312(5777):1171-5. PubMed ID: 16728631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Perspectives on chemotherapy of cancer of the bronchi].
    Chauvergne J; Chomy P
    Rev Mal Respir; 1989; 6(5):409-16. PubMed ID: 2557652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New approaches to adjuvant chemotherapy for breast cancer.
    Hudis C
    Pharmacotherapy; 1996; 16(3 Pt 2):88S-93S. PubMed ID: 8726587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of theoretical models to chemotherapy protocol design.
    Goldie JH; Coldman AJ
    Cancer Treat Rep; 1986 Jan; 70(1):127-31. PubMed ID: 3510731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical hyperthermia combined with drugs and radiation. A phase I/II study.
    Dahl O; Mella O; Mehus A; Liavaag PG
    Strahlenther Onkol; 1987 Jul; 163(7):446-8. PubMed ID: 3616903
    [No Abstract]   [Full Text] [Related]  

  • 27. Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts.
    Klement G; Huang P; Mayer B; Green SK; Man S; Bohlen P; Hicklin D; Kerbel RS
    Clin Cancer Res; 2002 Jan; 8(1):221-32. PubMed ID: 11801563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antitumor drug resistance and therapeutic approaches to reverse resistance].
    Tsuruo T
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1715-25. PubMed ID: 3899014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The genetic origin of drug resistance in neoplasms: implications for systemic therapy.
    Goldie JH; Coldman AJ
    Cancer Res; 1984 Sep; 44(9):3643-53. PubMed ID: 6744284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Principles of drug therapy of malignant tumors: the role of malignant progression in the choice of effective drugs].
    Jeney A; Rosta A
    Orv Hetil; 1999 May; 140(22):1245-9. PubMed ID: 10377736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combined treatment with radiotherapy and chemotherapy (author's transl)].
    Tubiana M
    Bull Cancer; 1981; 68(2):109-15. PubMed ID: 6263383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
    Holmes FA
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interaction.
    Kohn EC; Reed E; Sarosy GA; Minasian L; Bauer KS; Bostick-Bruton F; Kulpa V; Fuse E; Tompkins A; Noone M; Goldspiel B; Pluda J; Figg WD; Liotta LA
    Clin Cancer Res; 2001 Jun; 7(6):1600-9. PubMed ID: 11410496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized study of chemotherapy versus biochemotherapy with chemotherapy plus Aloe arborescens in patients with metastatic cancer.
    Lissoni P; Rovelli F; Brivio F; Zago R; Colciago M; Messina G; Mora A; Porro G
    In Vivo; 2009; 23(1):171-5. PubMed ID: 19368145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recent aspects of the chemotherapy of malignant tumors (author's transl)].
    Hartenstein R
    MMW Munch Med Wochenschr; 1978 Sep; 120(35):1127-32. PubMed ID: 308609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combining targeted drugs to stop resistant tumors.
    Kaiser J
    Science; 2011 Mar; 331(6024):1542-5. PubMed ID: 21436437
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunological aspects of resistance to antineoplastic chemotherapy].
    D'Alessandro N
    Clin Ter; 1991 Jul; 138(1):37-44. PubMed ID: 1834399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The individualized therapy of tumors].
    Mattern J; Volm M
    Dtsch Med Wochenschr; 1992 Oct; 117(44):1685-9. PubMed ID: 1425274
    [No Abstract]   [Full Text] [Related]  

  • 40. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.
    Goldie JH; Coldman AJ
    Cancer Treat Rep; 1979; 63(11-12):1727-33. PubMed ID: 526911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.